AAPL 258.8189 0.2397% MSFT 439.14 -0.0432% NVDA 140.185 -0.025% GOOGL 196.0128 -0.0496% GOOG 197.54 -0.0152% AMZN 227.87 -0.5152% META 603.74 -0.6598% AVGO 245.6915 2.5081% TSLA 452.9125 -2.0264% TSM 204.19 -1.0372% LLY 797.2122 0.1938% V 320.96 0.0967% JPM 242.37 0.0248% UNH 509.62 0.6955% NVO 87.85 0.5494% WMT 92.38 -0.3237% LVMUY 132.91 0.4459% XOM 106.31 -0.0846% LVMHF 664.0 0.9119% MA 536.2159 0.0944%
Last update at 2024-12-24T14:44:00Z
Alibaba Health Information Technology And 2 Other Stocks That Might Be Undervalued
Mon 30 Sep 24, 01:02 PM3 SEHK Growth Stocks With Up To 25% Insider Ownership
Mon 23 Sep 24, 11:01 PMSEHK Growth Companies With High Insider Ownership Include 3 Top Picks
Thu 05 Sep 24, 07:34 AMTop SEHK Growth Companies With High Insider Ownership August 2024
Wed 07 Aug 24, 07:35 AMSEHK Growth Companies With High Insider Ownership
Wed 31 Jul 24, 11:01 PMSEHK Growth Companies With High Insider Ownership And At Least 14% Earnings Growth
Tue 23 Jul 24, 11:03 PMSEHK Growth Companies With High Insider Ownership And Earnings Growth Up To 31%
Fri 19 Jul 24, 07:35 AMSEHK Growth Companies With High Insider Ownership And Up To 35% Earnings Growth
Thu 11 Jul 24, 07:35 AM| Breakdown | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
| Income before tax | 550.99M | -252.51400M | 401.22M | 9.09M | -60.83000M |
| Minority interest | -0.85600M | 0.39M | -20.34600M | -66.63000M | -57.69300M |
| Net income | 533.41M | -265.55500M | 348.59M | -6.58600M | -81.94900M |
| Selling general administrative | 379.49M | 395.08M | 293.60M | 219.97M | 181.02M |
| Selling and marketing expenses | 1768.67M | 1981.28M | 1222.01M | 722.72M | 454.84M |
| Gross profit | 5701.33M | 4107.99M | 3617.25M | 2231.38M | 1331.26M |
| Reconciled depreciation | 63.72M | 60.58M | 39.63M | 41.69M | 3.99M |
| Ebit | 493.11M | -792.29500M | 266.18M | -32.52500M | -62.95500M |
| Ebitda | 556.83M | -731.71900M | 305.81M | 9.16M | -58.96600M |
| Depreciation and amortization | 63.72M | 60.58M | 39.63M | 41.69M | 3.99M |
| Non operating income net other | - | - | - | - | - |
| Operating income | 493.11M | -792.29500M | 266.18M | -32.52500M | -62.95500M |
| Other operating expenses | 26794.80M | 21596.46M | 15407.64M | 9638.63M | 5189.20M |
| Interest expense | 5.83M | 3.81M | 2.45M | 21.96M | 27.97M |
| Tax provision | 16.73M | 13.43M | 58.54M | 24.79M | 30.93M |
| Interest income | 331.59M | 209.84M | 165.41M | 56.21M | 25.06M |
| Net interest income | -5.83300M | 206.02M | 162.97M | 34.25M | -2.91000M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 16.73M | 13.43M | 58.54M | 24.79M | 30.93M |
| Total revenue | 26763.02M | 20577.62M | 15518.47M | 9596.48M | 5095.87M |
| Total operating expenses | 5733.12M | 5126.84M | 3506.42M | 2273.53M | 1424.60M |
| Cost of revenue | 21061.68M | 16469.62M | 11901.22M | 7365.10M | 3764.60M |
| Total other income expense net | 57.89M | 539.78M | 135.04M | 41.62M | 2.12M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | 534.26M | -265.94100M | 342.68M | -15.69600M | -91.76400M |
| Net income applicable to common shares | - | -265.55500M | 348.59M | -6.58600M | -81.94900M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 |
| Total assets | 19705.34M | 20747.56M | 19201.97M | 17739.20M | 7869.97M |
| Intangible assets | 292.07M | 309.01M | 326.21M | 2.94M | 4.47M |
| Earning assets | - | - | - | - | - |
| Other current assets | 1774.25M | - | 63.12M | 11.02M | 60.24M |
| Total liab | 5187.73M | 5600.22M | 5129.74M | 3457.60M | 2667.46M |
| Total stockholder equity | 14544.21M | 15173.71M | 14098.42M | 14301.95M | 5269.15M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | 1551.83M | 1685.96M | 1242.88M | 828.99M | 712.35M |
| Common stock | 142.78M | 119.13M | 119.10M | 118.86M | 106.11M |
| Capital stock | 142.78M | 119.13M | 119.10M | 118.86M | 106.11M |
| Retained earnings | -11.97100M | -841.69100M | -1309.01300M | -985.65200M | -1297.06600M |
| Other liab | - | - | 222.85M | 39.32M | 19.83M |
| Good will | 810.85M | 810.85M | 810.85M | 54.58M | 54.58M |
| Other assets | - | - | 37.68M | 17.53M | 28.62M |
| Cash | 9553.11M | 10917.17M | 10547.85M | 11636.77M | 2594.98M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 5025.46M | 5437.44M | 4822.13M | 3400.87M | 2609.90M |
| Current deferred revenue | - | - | - | - | - |
| Net debt | -9470.94000M | -10839.37300M | -10412.43700M | -11599.02900M | -2525.22600M |
| Short term debt | 34.19M | 37.44M | 50.66M | 20.33M | 32.03M |
| Short long term debt | - | - | - | - | 0.00000M |
| Short long term debt total | 82.17M | 77.80M | 135.41M | 37.74M | 69.75M |
| Other stockholder equity | 14413.40M | 15896.26M | 13979.32M | 14183.09M | 5163.04M |
| Property plant equipment | - | - | 165.11M | 52.29M | 82.93M |
| Total current assets | 13512.24M | 14913.79M | 13565.51M | 14199.73M | 5013.00M |
| Long term investments | - | - | - | - | - |
| Net tangible assets | - | - | 12961.35M | 14244.44M | 5210.10M |
| Short term investments | -694.00000M | - | - | - | 402.49M |
| Net receivables | 785.14M | 578.08M | 1073.94M | 772.91M | 589.17M |
| Long term debt | - | - | - | - | - |
| Inventory | 1399.74M | 2102.31M | 1550.15M | 1468.61M | 1217.26M |
| Accounts payable | 3350.57M | 3714.05M | 3528.60M | 2551.55M | 1865.53M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | -36859.37500M | - | - | - | - |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | - |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 86.44M | 4611.52M | 4316.89M | 3429.68M | 434.82M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 6193.10M | 5833.77M | 5636.46M | 3539.48M | 2856.98M |
| Capital lease obligations | 82.17M | 77.80M | 135.41M | 37.74M | 69.75M |
| Long term debt total | - | - | - | - | - |
| Breakdown | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
| Investments | -532.43600M | 2799.35M | -4724.61400M | 1359.44M | -2383.12200M |
| Change to liabilities | 0.00000M | 1029.67M | 735.04M | 979.86M | 619.44M |
| Total cashflows from investing activities | - | 1872.31M | -4961.48400M | 1345.38M | -2395.71100M |
| Net borrowings | - | -47.01200M | -31.61600M | -1729.77300M | 1700.00M |
| Total cash from financing activities | -111.27800M | -58.62800M | 8922.41M | 328.81M | 1708.49M |
| Change to operating activities | - | -44.39200M | -122.06500M | -152.54400M | 66.00M |
| Net income | 550.99M | -252.51400M | 401.22M | 9.09M | -60.83000M |
| Change in cash | -104.57700M | 2089.15M | 4657.29M | 2314.61M | -228.04800M |
| Begin period cash flow | 9341.43M | 7252.27M | 2594.98M | 280.37M | 508.42M |
| End period cash flow | 9236.85M | 9341.43M | 7252.27M | 2594.98M | 280.37M |
| Total cash from operating activities | 255.69M | 424.36M | 1009.43M | 583.62M | 396.37M |
| Issuance of capital stock | 12.89M | 9.69M | 8993.71M | 2112.56M | 52.98M |
| Depreciation | 63.72M | 60.58M | 39.63M | 41.69M | 3.99M |
| Other cashflows from investing activities | - | -112.08600M | -234.52800M | 5.55M | -3.65900M |
| Dividends paid | - | - | - | - | 2293.54M |
| Change to inventory | -711.69400M | -129.20000M | -283.82600M | -638.96000M | -141.47300M |
| Change to account receivables | -64.62600M | -201.98300M | 7.44M | 41.80M | -275.29900M |
| Sale purchase of stock | -81.58200M | -16.51900M | -39.58000M | -17.81400M | -37.84600M |
| Other cashflows from financing activities | -42.58600M | -51.80200M | -31.72600M | -65.93400M | 2297.52M |
| Change to netincome | - | -24.75600M | 284.62M | 318.36M | 205.66M |
| Capital expenditures | 5.92M | 15.12M | 17.56M | 13.51M | 6.10M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | -568.13000M | 671.12M | 294.65M | 233.94M | 268.01M |
| Stock based compensation | 308.89M | 408.10M | 396.96M | 277.14M | 213.49M |
| Other non cash items | -99.78300M | -462.92200M | -123.02500M | 21.75M | -28.28800M |
| Free cash flow | 249.77M | 409.25M | 991.87M | 570.10M | 390.27M |
Sector: Healthcare Industry: Pharmaceutical Retailers
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| ALBBY Alibaba Health Information Technology Limited |
0.04 0.50% | 8.98 | 48.10 | 30.30 | 0.29 | 3.70 | 1.58 | 34.83 |
| WBA Walgreens Boots Alliance Inc |
0.42 4.62% | 9.62 | - | 5.40 | 0.11 | 1.14 | 0.33 | -4.3066 |
| RADLY Raia Drogasil SA ADR |
0.12 3.86% | 3.23 | 47.15 | 32.68 | 0.34 | 9.83 | 0.35 | 3.29 |
| ALBHF Alibaba Health Information Technology Limited |
0.005 1.14% | 0.45 | 50.80 | 29.59 | 0.30 | 3.62 | 1.58 | 34.83 |
| SHPPF Shop Apotheke Europe N.V |
-20.84 13.03% | 139.16 | - | - | 2.80 | 2.28 | 1.70 | 78.78 |
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, health food, adult and family planning products, healthcare and skincare products, and various other health-related products. It also provides medical and healthcare services, including medical checkups, nucleic acid testing, medical consultation, appointment-booking, vaccination, dental care, mental care, optometry, and nursing services, as well as traditional Chinese medicines. The company provides is products and services to business-to-customer and business-to-business customers through offline pharmacy outlets, as well as online stores, such as Tmall, Taobao, Alipay, Ele.me, AMap, DingTalk, Freshippo, and Quark. In addition, it engages in the digital tracking business; provision of network hospital, software technical services, healthcare related internet information and technical services; operation of internet hospitals, as well as Doctor U, an intelligent and one-stop platform for doctor and patient education; and asset management services. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. Alibaba Health Information Technology Limited was incorporated in 1998 and is based in Causeway Bay, Hong Kong.
Tower One, Causeway Bay, Hong Kong
| Name | Title | Year Born |
|---|---|---|
| Mr. Shunyan Zhu | Chairman & CEO | 1971 |
| Mr. Yanwu Tu | CFO & Exec. Director | 1979 |
| Mr. Difan Shen | COO & Exec. Director | 1979 |
| Mr. Chun Chung Kwong | Financial Controller | NA |
| Ms. Chun Ka Yan | Company Sec. | NA |
| Ka Yan Chun | Company Sec. | NA |
| Mr. Difan Shen | CEO & Executive Director | 1978 |
| Mr. Yanwu Tu | CFO & Executive Director | 1979 |
| Ms. Hiu Leong Tsui | Legal Counsel & Joint Company Secretary | NA |
| Ms. Yin Rui | Chief Marketing Officer | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
US 
AU
UK
CA
NZ
Please wait processing your request...